ARTG 382679Glaucoma shunt
ARTG ID: 382679 · RQSolutions Medical Devices Distribution Support · Glaukos Corporation · Class IIb · Started January 17, 2022
Good Name: RQSolutions Medical Devices Distribution Support - Glaucoma shunt
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 382679
- Start Date
- January 17, 2022
- Effective Date
- January 17, 2022
- Country
- United States of America
- Address
- 229 Avenida Fabricante, San Clemente, CA, 92672
The MicroShunt is intended for reduction of intraocular pressure in eyes of patients with primary open angle glaucoma where IOP remains uncontrollable while on maximum tolerated medical therapy and/or where glaucoma progression warrants surgery.
Access comprehensive regulatory information for Glaucoma shunt in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 382679 and sponsored by RQSolutions Medical Devices Distribution Support, manufactured by Glaukos Corporation in United States of America. The device registration started on January 17, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.